Vanderhoff Anna, Lanes Andrea, Ginsburg Elizabeth
Reprod Fertil. 2024 Dec 20;5(4). doi: 10.1530/RAF-24-0099. Print 2024 Oct 1.
Our objective is to investigate whether infertile women with a history of levonorgestrel intrauterine device (LNG IUD) use have impaired endometrial growth and pregnancy rates after embryo transfer. This is a retrospective cohort study at a single academic medical center of infertile women aged 18-44 with a history of LNG IUD use undergoing their first embryo transfer cycle between January 2019 and January 2021 compared to controls with a history of no prior birth control use (NONE) or prior oral contraceptive (OCP) use. The primary outcome is endometrial thickness prior to embryo transfer. Secondary outcomes are embryo transfer results, including implantation, miscarriage and live birth. Demographic, baseline and cycle characteristics were similar among the three groups. Women with a history of LNG IUD use had thinner endometrial stripes than women with a history of NONE (LNG IUD: 8.93 mm, NONE: 10.32 mm (aRR: 0.88, 95% CI: 0.80-0.97)) but not when compared to women with a history of OCP use (OCP: 9.61 mm (aRR: 0.92, 95% CI: 0.84-1.01)). Women with a history of LNG IUD use had slightly higher implantation rates than those with NONE history (LNG IUD: 43.37%, NONE: 24.17% (relative risk (RR): 1.79, 95% CI: 1.21-2.45)), though not when compared to prior OCP users (OCP: 38.72% (RR: 1.12, 95% CI: 0.86-1.47)). The remainder of the embryo transfer outcomes were similar among the three groups. In conclusion, prior LNG IUD users have a reduced endometrial thickness at the time of embryo transfer but do not have worse pregnancy outcomes.
LNG IUDs (brand names include Mirena, Liletta and Skyla) are some of the most widely used forms of birth control. While these devices are safe and are generally not believed to impact fertility, a few recent articles have suggested the possibility of a long-term impact of prior intrauterine device use on the uterine lining in some patients. As such, we sought to examine uterine lining growth and outcomes of assisted reproduction in an infertile patient population with a history of LNG IUD use compared to infertile women without a history of LNG IUD use. Ultimately, we found that women with a history of LNG IUD use had less uterine lining growth during assisted reproduction cycles, but that they did not have worse pregnancy outcomes when compared to women without a history of levonorgestrel device use.
我们的目的是调查有左炔诺孕酮宫内节育器(LNG IUD)使用史的不孕女性在胚胎移植后子宫内膜生长和妊娠率是否受损。这是一项在单一学术医疗中心进行的回顾性队列研究,研究对象为年龄在18 - 44岁、有LNG IUD使用史且在2019年1月至2021年1月期间进行首次胚胎移植周期的不孕女性,并与无既往避孕史(无)或既往口服避孕药(OCP)使用史的对照组进行比较。主要结局是胚胎移植前的子宫内膜厚度。次要结局是胚胎移植结果,包括着床、流产和活产。三组之间的人口统计学、基线和周期特征相似。有LNG IUD使用史的女性子宫内膜条纹比无使用史的女性薄(LNG IUD:8.93毫米,无:10.32毫米(调整后风险比:0.88,95%置信区间:0.80 - 0.97)),但与有OCP使用史的女性相比则不然(OCP:9.61毫米(调整后风险比:0.92,95%置信区间: - 1.01))。有LNG IUD使用史的女性着床率略高于无使用史的女性(LNG IUD:43.37%,无:24.17%(相对风险(RR):1.79,95%置信区间:1.21 - 2.45)),不过与既往OCP使用者相比则不然(OCP:38.72%(RR:1.12,95%置信区间:0.86 - 1.47))。三组之间其余的胚胎移植结局相似。总之,既往使用LNG IUD的女性在胚胎移植时子宫内膜厚度降低,但妊娠结局并不更差。
LNG IUD(商品名包括曼月乐、利悦和思悦)是一些使用最广泛的避孕方式。虽然这些装置是安全的,且一般认为不会影响生育能力,但最近的几篇文章表明,既往使用宫内节育器可能会对一些患者的子宫内膜产生长期影响。因此,我们试图研究有LNG IUD使用史的不孕患者群体与无LNG IUD使用史的不孕女性相比,其子宫内膜生长情况和辅助生殖结局。最终,我们发现有LNG IUD使用史的女性在辅助生殖周期中子宫内膜生长较少,但与无左炔诺孕酮装置使用史的女性相比,她们的妊娠结局并不更差。